A comparison of the behavioral and anatomical outcomes in sub-acute and chronic spinal cord injury models following treatment with human mesenchymal precursor cell transplantation and recombinant decorin-Reference-Cited by-同舟云学术

A comparison of the behavioral and anatomical outcomes in sub-acute and chronic spinal cord injury models following treatment with human mesenchymal precursor cell transplantation and recombinant decorin

Published:2013-10 Issue: Volume:248 Page:343-359
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Hodgetts Stuart I.,Simmons Paul J.,Plant Giles W.

Funder

The Victorian Neurotrauma Initiative, Step Ahead Australia

The Neurotrauma Research Program of Western Australia

Eileen Bond

The Australasian Spinal Research Trust

The James Doty Neurosurgery Fund

Stanford University

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference74 articles.

1. Human mesenchymal stem cells modulate allogeneic immune cell responses;Aggarwal;Blood,2005

2. Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts;Al Haj Zen;Matrix Biol.,2003

3. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: a novel method for minimally invasive cell transplantation;Bakshi;J. Neurotrauma,2006

4. Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation;Barkho;Stem Cells Dev.,2006

5. A sensitive and reliable locomotor rating scale for open field testing in rats;Basso;J. Neurotrauma,1995

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Optimal Number of Implanted Mesenchymal Stem Cells for the Treatment of Post-Traumatic Syrinx and Recovery of Motor Activity after Chronic Spinal Cord Injury;Bulletin of Experimental Biology and Medicine;2023-08

2. Effects of amyloid precursor protein peptide APP96-110, alone or with human mesenchymal stromal cells, on recovery after spinal cord injury;Neural Regeneration Research;2022

3. Cell therapy and delivery strategies for spinal cord injury;HISTOL HISTOPATHOL;2021

4. Peptide Hydrogel Scaffold for Mesenchymal Precursor Cells Implanted to Injured Adult Rat Spinal Cord;Tissue Engineering Part A;2021-08-01

5. Mesenchymal Stem Cell Therapies for Paraplegia: Preclinical and Clinical Studies;Paraplegia;2021-05-12